Gary Woodnutt
Keine laufenden Positionen mehr
Karriereverlauf von Gary Woodnutt
Ehemalige bekannte Positionen von Gary Woodnutt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONTRAFECT CORPORATION | Corporate Officer/Principal | 17.06.2021 | 04.12.2023 |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 16.04.2013 | 14.10.2016 |
Tanabe Research Laboratories U.S.A., Inc.
 Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Gary Woodnutt
| The University of Reading | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Tanabe Research Laboratories U.S.A., Inc.
Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Gary Woodnutt
- Erfahrung